Importantly, QGY treatment promotes osteoblast differentiation and enhances osteogenic capacity by targeting CKIP-1 mediated AKT/mTOR pathway activation and autophagy inhibition (rather than osteoclasts), thereby playing a role in improving osteoporosis (Figure 7). Here, AKT1 is linked to osteoporosis.